[go: up one dir, main page]

NZ766927A - Chimeric receptors and methods of use thereof - Google Patents

Chimeric receptors and methods of use thereof

Info

Publication number
NZ766927A
NZ766927A NZ766927A NZ76692717A NZ766927A NZ 766927 A NZ766927 A NZ 766927A NZ 766927 A NZ766927 A NZ 766927A NZ 76692717 A NZ76692717 A NZ 76692717A NZ 766927 A NZ766927 A NZ 766927A
Authority
NZ
New Zealand
Prior art keywords
methods
chimeric receptors
antigen binding
immune cells
binding molecules
Prior art date
Application number
NZ766927A
Other versions
NZ766927B2 (en
Inventor
Jed Wiltzius
Rodriguez Ruben Alvarez
Alice Bakker
Tara Arvedson
Lawren Wu
Original Assignee
Amgen Inc
Kite Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Kite Pharma Inc filed Critical Amgen Inc
Priority to NZ786742A priority Critical patent/NZ786742B2/en
Publication of NZ766927A publication Critical patent/NZ766927A/en
Publication of NZ766927B2 publication Critical patent/NZ766927B2/en

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

Antigen binding molecules, chimeric receptors, and engineered immune cells against C-type lectin-like-1 (CLL-1) receptor are disclosed in accordance with the invention. The invention further relates to vectors, compositions, and methods of treatment and/or detection using the antigen binding molecules and engineered immune cells.
NZ766927A 2017-03-31 Chimeric receptors and methods of use thereof NZ766927B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ786742A NZ786742B2 (en) 2017-03-31 Chimeric receptors and methods of use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662317068P 2016-04-01 2016-04-01
NZ74717217 2017-03-31

Publications (2)

Publication Number Publication Date
NZ766927A true NZ766927A (en) 2025-05-30
NZ766927B2 NZ766927B2 (en) 2025-09-02

Family

ID=

Similar Documents

Publication Publication Date Title
PH12018502113A1 (en) Chimeric receptors and methods of use thereof
ZA202006943B (en) Chimeric receptors to dll3 and methods of use thereof
MY201207A (en) Chimeric receptors to flt3 and methods of use thereof
MX2017001013A (en) CANCER TREATMENT USING A CLL-1 ANTIGEN CHEMICAL RECEIVER.
PH12021550120A1 (en) Chimeric receptors to steap1 and methods of use thereof
ZA201708265B (en) Tigit-binding agents and uses thereof
MY181834A (en) Treatment of cancer using humanized anti-bcma chimeric antigen receptor
PH12017501039A1 (en) Antibodies targeting g-protein coupled receptor and methods of use
SA517381703B1 (en) Anti-C10orf54 Antibodies And Uses Thereof
MY189028A (en) Anti-cd123 chimeric antigen receptor (car) for use in cancer treatment
NZ749292A (en) Compositions and methods related to engineered fc constructs
PH12016501644B1 (en) Binding proteins and methods of use thereof
MX2016010953A (en) Multimeric fc proteins.
NZ766927A (en) Chimeric receptors and methods of use thereof
HK1231768A1 (en) Treatment of cancer using a cll-1 chimeric antigen receptor
HK1231900A1 (en) Treatment of cancer using humanized anti-bcma chimeric antigen receptor

Legal Events

Date Code Title Description
PSEA Patent sealed
S38C Proceedings under section 38 (amendment of specification with leave of commissioner): specification amended